Mouse models for nuclear DNA-encoded mitochondrial complex I deficiency

Journal of Inherited Metabolic Disease

Volumn 34, Issue 2, 2011, Pages 293-307

  Koene, Saskia ^a   Willems, Peter H G M ^b   Roestenberg, Peggy ^b   Koopman, Werner J H ^b   Smeitink, Jan A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; APOPTOSIS INDUCING FACTOR; CALCIUM ION; CELL NUCLEUS DNA; IRON SULFUR PROTEIN; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SIRTUIN; SUCCINATE DEHYDROGENASE (UBIQUINONE); TROLOX C;

CALCIUM HOMEOSTASIS; CELL ACTIVITY; CELL STRUCTURE; COMPLEX I DEFICIENCY; DISEASE MODEL; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME STRUCTURE; GENE; GENE MUTATION; GENE THERAPY; GENETIC REGULATION; MOUSE; NDUFS4 GENE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; CELL NUCLEUS; DISEASE MODELS, ANIMAL; DNA; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX I; HUMANS; MICE; MICE, KNOCKOUT; MITOCHONDRIAL DISEASES; MODELS, BIOLOGICAL; OXIDATIVE PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; TREATMENT OUTCOME;

EID: 79955684143     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-9005-x     Document Type: Review

References (94)

1. Anderson SL, Chung WK, Frezzo J (2008) A novel mutation in NDUFS4 causes Leigh syndrome in an Ashkenazi Jewish family. J Inherit Metab Dis. doi:10.1007/s10545-008-1049-9
2. Balaban RS, Nemoto S, Finkel T (2005) Mitochondria, oxidants, and aging. Cell 120:483-495 (Pubitemid 40269763)
3. Benit P, Steffann J, Lebon S et al (2003) Genotyping microsatellite DNA markers at putative disease loci in inbred/multiplex families with respiratory chain complex I deficiency allows rapid identification of a novel nonsense mutation (IVS1nt -1) in the NDUFS4 gene in Leigh syndrome. Hum Genet 112:563-566 (Pubitemid 36869050)
4. Benit P, Goncalves S, Dassa EP et al (2008) The variability of the harlequinmouse phenotype resembles that of humanmitochondrial-complex I-deficiency syndromes. PLoS ONE 3:e3208
5. Berridge MJ, Bootman MD, Roderick HL (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4:517-529 (Pubitemid 36773404)
6. Betts J, Lightowlers RN, Turnbull DM(2004) Neuropathological aspects of mitochondrial DNA disease. Neurochem Res 29:505-511 (Pubitemid 38295001)
7. Brandt U (2006) Energy converting NADH:quinone oxidoreductase (complex I). Annu Rev Biochem 75:69-92
8. Brini M, Pinton P, King MP et al (1999) A calcium signaling defect in the pathogenesis of a mitochondrial DNA inherited oxidative phosphorylation deficiency. Nat Med 5:951-954 (Pubitemid 29372425)
9. Brown MD, Starikovskaya E, Derbeneva O et al (2002) The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup J. Hum Genet 110:130-138 (Pubitemid 36067429)
10. Budde SM, van den Heuvel LP, Smeitink JA (2002) The human complex I NDUFS4 subunit: from gene structure to function and pathology. Mitochondrion 1-2:109-115 (Pubitemid 35214602)
11. Budde SM, van den Heuvel LP, Smeets RJ et al (2003) Clinical heterogeneity in patients with mutations in the NDUFS4 gene of mitochondrial complex I. J Inherit Metab Dis 26:813-815 (Pubitemid 38139383)
12. Caboni P, Sherer TB, Zhang N (2004) Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease. Chem Res Toxicol 17:1540-1548 (Pubitemid 39532322)
13. Cande C, Vahsen N, Kouranti I et al (2004) AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene 23:1514-1521 (Pubitemid 38406513)
14. Carroll J, Shannon RJ, Fearnley IM et al (2002) Definition of the nuclear encoded protein composition of bovine heart mitochondrial complex I. Identification of two new subunits. J Biol Chem 277:50311-50317
15. Cheung EC, Joza N, Steenaart NA et al (2006) Dissociating the dual roles of apoptosis-inducing factor in maintaining mitochondrial structure and apoptosis. EMBO J 25:4061-4073 (Pubitemid 44338747)
16. Choi WS, Kruse SE, Palmiter RD et al (2008) Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proc Natl Acad Sci U S A 105: 15136-15141
17. Ciafaloni E, Santorelli FM, Shanske S et al (1993) Maternally inherited Leigh syndrome. J Pediatr 122:419-422 (Pubitemid 23067225)
18. Debray FG, Lambert M, Chevalier I et al (2007) Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases. Pediatrics 119:722-733 (Pubitemid 46556671)
19. DiMauro S, Schon EA (2003) Mitochondrial respiratory-chain diseases. N Engl J Med 348:2656-2668 (Pubitemid 36741594)
20. Distelmaier F, Koopman WJ, van den Heuvel LP (2009a) Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease. Brain 132(Pt 4):833-842
21. Distelmaier F, Visch HJ, Smeitink JA (2009b) The antioxidant Trolox restores mitochondrial membrane potential and Ca2+ -stimulated ATP production in human complex I deficiency. J Mol Med 87:515-522
22. van Empel V, Bertrand AT, Van der NR (2005) Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation. Circ Res 496:e92-e101
23. van Empel V, Bertrand AT, van Oort RJ (2006) EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant. J Am Coll Cardiol 48:824-832 (Pubitemid 44175721)
24. Fernandez-Moreira D, Ugalde C, Smeets R (2007) Arenas J. X-linked NDUFA1 gene mutations associated with mitochondrial encephalomyopathy. Ann Neurol 61:73-83
25. Gattermann N, Dadak M, Hofhaus G (2004) Severe impairment of nucleotide synthesis through inhibition of mitochondrial respiration. Nucleosides Nucleotides Nucleic Acids 23:1275-1279 (Pubitemid 39625911)
26. El Ghouzzi V, Csaba Z, Olivier P (2007) Apoptosis-inducing factor deficiency induces early mitochondrial degeneration in brain followed by progressive multifocal neuropathology. J Neuropathol Exp Neurol 66:838-847 (Pubitemid 47360959)
27. van den Heuvel L, Ruitenbeek W, Smeets R et al (1998) Demonstration of a new pathogenic mutation in human complex I deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit. Am J Hum Genet 62:262-268 (Pubitemid 28110767)
28. Hirst J, Carroll J, Fearnley IM (2003) The nuclear encoded subunits of complex I from bovine heart mitochondria. Biochim Biophys Acta 1604:135-150 (Pubitemid 36776747)
29. Hoefs SJ, Dieteren CE, Distelmaier F (2008) NDUFA2 complex I mutation leads to Leigh disease. Am J Hum Genet 82:1306-1315
30. Iuso A, Scacco S, Piccoli C (2006) Dysfunctions of cellular oxidative metabolism in patients with mutations in the NDUFS1 and NDUFS4 genes of complex I. J Biol Chem 281:10374-10380 (Pubitemid 43864576)
31. Janssen R, Smeitink J, Smeets R (2002) CIA30 complex I assembly factor: a candidate for human complex I deficiency? Hum Genet 110:264-270
32. Janssen RJ, van den Heuvel LP, Smeitink JA (2004) Genetic defects in the oxidative phosphorylation (OXPHOS) system. Expert Rev Mol Diagn 4:143-156 (Pubitemid 38327245)
33. Janssen RJ, Nijtmans LG, van den Heuvel LP (2006) Mitochondrial complex I: structure, function and pathology. J Inherit Metab Dis 29:499-515 (Pubitemid 44193264)
34. Joza N, Oudit GY, Brown D et al (2005) Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol Cell Biol 25:10261-10272 (Pubitemid 41681953)
35. Klein JA, Longo-Guess CM, Rossmann MP et al (2002) The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419:367-374
36. Koene S, Smeitink J (2009) Mitochondrial medicine: entering the era of treatment. J Intern Med 265:193-209
37. Koopman WJ, Verkaart S, Visch HJ et al (2005a) Inhibition of complex I of the electron transport chain causes O2-. -mediated mitochondrial outgrowth. Am J Physiol Cell Physiol 288:C1440-C1450 (Pubitemid 40991081)
38. Koopman WJ, Visch HJ, Verkaart S et al (2005b) Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency. Am J Physiol Cell Physiol 289:C881-C890 (Pubitemid 41361644)
39. Koopman WJ, Visch HJ, Smeitink JA et al (2006) Simultaneous quantitative measurement and automated analysis of mitochondrial morphology, mass, potential, and motility in living human skin fibroblasts. Cytometry A 69:1-12 (Pubitemid 43062691)
40. Koopman WJ, Hink MA, Verkaart S et al (2007a) Partial complex I inhibition decreases mitochondrial motility and increases matrix protein diffusion as revealed by fluorescence correlation spectroscopy. Biochim Biophys Acta 1767:940-947 (Pubitemid 47031093)
41. Koopman WJ, Verkaart S, Visch HJ (2007b) Human NADH: ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology? Am J Physiol Cell Physiol 293:C22-C29
42. Koopman WJ, Distelmaier F, Hink MA et al (2008a) Inherited complex I deficiency is associated with faster protein diffusion in the matrix of moving mitochondria. Am J Physiol Cell Physiol 294:C1124-C1132
43. Koopman WJ, Verkaart S, van Emst-de Vries SE et al (2008b) Mitigation of NADH: ubiquinone oxidoreductase deficiency by chronic Trolox treatment. Biochim Biophys Acta 1777:853-859
44. Kruse SE, Watt WC, Marcinek DJ et al (2008) Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy. Cell Metab 7:312-320 (Pubitemid 351455216)
45. Larsson NG, Rustin P (2001) Animal models for respiratory chain disease. Trends Mol Med 7:578-581
46. Lash LH (2006) Mitochondrial glutathione transport: physiological, pathological and toxicological implications. Chem Biol Interact 163:54-67
47. Lazarou M, McKenzie M, Ohtake A (2007) Analysis of the assembly profiles for mitochondrial- and nuclear-DNA-encoded subunits into complex I. Mol Cell Biol 27:4228-4237 (Pubitemid 46906548)
48. Lazarou M, Thorburn DR, Ryan MT et al (2009) Assembly of mitochondrial complex I and defects in disease. Biochim Biophys Acta 1793:78-88
49. Leshinsky-Silver E, Lebre AS, Minai L (2009) NDUFS4 mutations cause Leigh syndrome with predominant brainstem involvement. Mol Genet Metab 3:185-189
50. Leigh D (1951) Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 14:216-221
51. Leonard JV, Schapira AH (2000) Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet 355:299-304 (Pubitemid 30068529)
52. Loeffen JL, Smeitink JA, Trijbels JM, Janssen AJ et al (2000) Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat 15:123-134 (Pubitemid 30078403)
53. Melov S, Doctrow SR, Schneider JA et al (2001) Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J Neurosci 21:8348-8353 (Pubitemid 33051432)
54. Milne JC, Denu JM (2008) The Sirtuin family: therapeutic targets to treat diseases of aging. Curr Opin Chem Biol 12:11-17
55. Morgan-Hughes JA, Darveniza P, Landon DN et al (1979) A mitochondrial myopathy with a deficiency of respiratory chain NADH-CoQ reductase activity. J Neurol Sci 43:27-46 (Pubitemid 9220250)
56. Mortiboys H, Thomas KJ, Koopman WJ et al (2009) Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurology 64:555-565
57. Murphy MP (2008) Targeting lipophilic cations to mitochondria. Biochim Biophys Acta 1777:1028-1031
58. Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417:1-13
59. Murphy MP, Smith RA (2007) Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 56:629-656
60. Nguyen MH, Jafri MS (2005) Mitochondrial calcium signaling and energy metabolism. Ann N Y Acad Sci 1047:127-137
61. Nicholls DG (2005) Mitochondria and calcium signaling. Cell Calcium 38:311-317
62. Palmieri L, Runswick MJ, Fiermonte G (2000) Yeast mitochondrial carriers: bacterial expression, biochemical identification and metabolic significance. J Bioenerg Biomembr 32:67-77 (Pubitemid 30241259)
63. Papa S, Scacco S, Sardanelli AM (2001) Mutation in the NDUFS4 gene of complex I abolishes cAMP-dependent activation of the complex in a child with fatal neurological syndrome. FEBS Lett 489:259-262 (Pubitemid 32126420)
64. Petruzzella V, Papa S (2002) Mutations in human nuclear genes encoding for subunits of mitochondrial respiratory complex I: the NDUFS4 gene. Gene 286:149-154 (Pubitemid 34273872)
65. Petruzzella V, Panelli D, Torraco A, Petruzzella V, Panelli D, Torraco A (2005) Mutations in the NDUFS4 gene of mitochondrial complex I alter stability of the splice variants. FEBS Lett 579:3770-3776 (Pubitemid 40897723)
66. Pospisilik JA, Knauf C, Joza N et al (2007) Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 131:476-491 (Pubitemid 350017761)
67. Qi X, Lewin AS, Hauswirth WW et al (2003) Optic neuropathy induced by reductions in mitochondrial superoxide dismutase. Invest Ophthalmol Vis Sci 44:1088-1096 (Pubitemid 36297826)
68. Qi X, Sun L, Hauswirth WW et al (2007) Use of mitochondrial antioxidant defenses for rescue of cells with a Leber hereditary optic neuropathy-causing mutation. Arch Ophthalmol 125:268-272
69. Rahman S, Blok RB, Dahl HH et al (1996) Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 39:343-351 (Pubitemid 26100758)
70. Saada A, Vogel RO, Hoefs SJ (2009) Mutations in NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting complex I assembly protein, cause fatal neonatal mitochondrial disease. Am J Hum Genet 6:718-727
71. Santorelli FM, Tanji K, Kulikova R et al (1997) Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. Biochem Biophys Res Commun 238:326-328 (Pubitemid 27464381)
72. Scacco S, Vergari R, Scarpulla RC et al (2000) cAMP-dependent phosphorylation of the nuclear encoded 18-kDa (IP) subunit of respiratory complex I and activation of the complex in serum-starved mouse fibroblast cultures. J Biol Chem 275:17578-17582 (Pubitemid 30430802)
73. Schapira AH, Cock HR (1999) Mitochondrial myopathies and encephalomyopathies. Eur J Clin Invest 29:886-898 (Pubitemid 29479107)
74. Schon EA, Manfredi G (2003) Neuronal degeneration and mitochondrial dysfunction. J Clin Invest 111:303-312 (Pubitemid 36182203)
75. Smeitink J, van den Heuvel L, DiMauro S (2001) The genetics and pathology of oxidative phosphorylation. Nat Rev Genet 2:342-352 (Pubitemid 33673072)
76. Smeitink JA, Zeviani M, Turnbull DM et al (2006) Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab 3:9-13
77. Susin SA, Lorenzo HK, Zamzami N et al (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397(6718):441-446
78. Szabò I, Bock J, Jekle A, Soddemann M (2005) A novel potassium channel in lymphocyte mitochondria. J Biol Chem 280:12790-12798
79. Szeto HH (2006) Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. AAPS J 8:E521-E531
80. Tavi P, Hansson A, Zhang SJ et al (2005) Abnormal Ca(2+) release and catecholamine-induced arrhythmias in mitochondrial cardiomyopathy. Hum Mol Genet 14:1069-1076 (Pubitemid 40575882)
81. Ugalde C, Janssen RJ, van den Heuvel LP et al (2004) Differences in assembly or stability of complex I and other mitochondrial OXPHOS complexes in inherited complex I deficiency. Hum Mol Genet 13:659-667 (Pubitemid 38379855)
82. Vahsen N, Cande C, Briere JJ et al (2004) AIF deficiency compromises oxidative phosphorylation. EMBO J 23:4679-4689 (Pubitemid 39657867)
83. Valsecchi F, Esseling JJ, Koopman WJ (2009) Calcium and ATP handling in human NADH:ubiquinone oxidoreductase deficiency. Biochim Biophys Acta 10 ePub
84. Verkaart S, Koopman WJ, Cheek J et al (2007a) Mitochondrial and cytosolic thiol redox state are not detectably altered in isolated human NADH:ubiquinone oxidoreductase deficiency. Biochim Biophys Acta 1772:1041-1051 (Pubitemid 47314228)
85. Verkaart S, Koopman WJ, van Emst-de Vries SE (2007b) Superoxide production is inversely related to complex I activity in inherited complex I deficiency. Biochim Biophys Acta 1772:373-381 (Pubitemid 46275438)
86. Visch HJ, Rutter GA, Koopman WJ et al (2004) Inhibition of mitochondrial Na+-Ca2+ exchange restores agonist-induced ATP production and Ca2+ handling in human complex I deficiency. J Biol Chem 279:40328-40336 (Pubitemid 39287618)
87. Visch HJ, Koopman WJ, Leusink A et al (2006a) Decreased agonist-stimulated mitochondrial ATP production caused by a pathological reduction in endoplasmic reticulum calcium content in human complex I deficiency. Biochim Biophys Acta 1762:115-123 (Pubitemid 43021094)
88. Visch HJ, Koopman WJ, Zeegers D (2006b) Ca2+-mobilizing agonists increase mitochondrial ATP production to accelerate cytosolic Ca2+ removal: aberrations in human complex I deficiency. Am J Physiol Cell Physiol 291:C308-C316 (Pubitemid 44148154)
89. Vogel R, Nijtmans L, Ugalde C et al (2004) Complex I assembly: a puzzling problem. Curr Opin Neurol 17:179-186 (Pubitemid 38446461)
90. Willems PH, Valsecchi F, Distelmaier F et al (2008) Mitochondrial Ca2+ homeostasis in human NADH:ubiquinone oxidoreductase deficiency. Cell Calcium 44:123-133
91. Whishaw IQ, Kolb B (1983) Motor systems and regulatory systems In: Whishaw IQ, Kolb B (eds) The behavior of the laboratory rat. Oxford University Press, pp 121-245
92. Wispe JR, Warner BB, Clark JC et al (1992) Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J Biol Chem 25267: 23937-23941 (Pubitemid 23088207)
93. Zeviani M, Spinazzola A, Carelli V (2003) Nuclear genes in mitochondrial disorders. Curr Opin Genet 13:262-270 (Pubitemid 36645089)
94. Zickermann V, Kerscher S, Zwicker K (2009) Architecture of complex I and its implications for electron transfer and proton pumping. Biochim Biophys Acta 6:574-583